CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 204 enrolled
Drug / intervention
PICOPREPdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02239692
NCT02239692Phase 3Completed
CompareCT.gov

A Randomised, Assessor-blinded, Multi-centre Trial Comparing the Efficacy, Safety and Tolerability of the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy

Ferring Pharmaceuticals·interventional·Posted Sep 15, 2014·Updated Jun 23, 2016

In Brief

A Phase 3 clinical trial evaluating PICOPREP for Bowel Cleansing. Completed, enrolled 204 participants across 3 sites in 3 countries.

Detailed Summary

This was a phase 3, randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of a PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon cleansing in preparation for colonoscopy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBowel Cleansing
CountriesFrance, Germany, Netherlands
Collaborators--

Timeline

Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 15, 2014
Enrollment StartNov 1, 2014
Primary CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.8 years ago

Interventions

PICOPREPdrug

Sodium Picosulfate, Magnesium Oxide and Citric Acid as PICOPREP powder for oral solution